NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

APO - Acasti Pharma Inc

Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. The Company’s product portfolio includes concentrat","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# APOhart

Acasti Pharma Inc News


Amarin: Most Undervalued Name In Biotech?
Seeking Alpha - May 13, 2012
Before I dig into the article, I just wanted to express my thanks to the SA community, as I have been an avid reader for quite some time of many in the healthcare sector.

Equity Briefing: NFL's John Elway scheduled to pitch Neptune during CNBC and ...
Reuters - May 10, 2012
Shares of Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) (NTB.TO) were up over 7% and rising in anticipation of two news features scheduled for national television on Thursday.

Neptune Confirms Its Pre-eminence in the Australian Market
MarketWatch (press release) - May 8, 2012
LAVAL, Quebec, May 8, 2012 (GlobeNewswire via COMTEX) -- Neptune Technologies & Bioressources Inc. ("Neptune") (UTD:NEPT) (TOR:CA:NTB) announces that Aker Biomarine's newly granted Australian patent (AU2008231570) has no impact on Neptune's position as ...

NKO(R) Ambassador John Elway to Speak at SupplySide MarketPlace (NYC) and to ...
Stockhouse - May 3, 2012
LAVAL, Quebec, May 3, 2012 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) today announced that John Elway will be speaking at SupplySide MarketPlace on May 10, 2012 at the Javits Center in New York ...

NKO(R) Ambassador John Elway to Speak at SupplySide MarketPlace (NYC) and to ...
MarketWatch (press release) - May 3, 2012
LAVAL, Quebec, May 3, 2012 (GlobeNewswire via COMTEX) -- Neptune Technologies & Bioressources Inc. ("Neptune") (UTD:NEPT) (TOR:CA:NTB) today announced that John Elway will be speaking at SupplySide MarketPlace on May 10, 2012 at the Javits Center in ...

Solid Fundamental Bet: Shares Of Marine Omega-3 Phospholipids Leader Ready Climb
Seeking Alpha - Apr 26, 2012
We've been telling Seeking Alpha readers that Neptune Technologies and Bioresources (NEPT) was easily one of the most compelling stocks we had run across since it was trading at $2.

Equity Briefing: Exec hints at doubling revenues and a possible spin-off ...
Reuters - Apr 25, 2012
Wael Massrieh, the VP of Scientific affairs for Neptune Technologies and Bioresources (NASDAQ: NEPT), in a videotaped interview on Wednesday hinted that his firm will see a substantial increase in revenues due to their plant expansion roll-out.
A Rare, De-Risked Break-Out Stock For Healthcare Investors - Proactive Investors USA & Canada

A Rare, De-Risked Break-Out Stock For Healthcare Investors
BioMedReports (subscription) - Apr 25, 2012
By MEGarza Not only are shares of this healthcare sector stock just starting to break-out technically, fundamental indicators are also pointing to higher prices ahead.

TSX Media Coverage Selection of the best articles found in your favorit medias

Next Company >>